ATAI Life Sciences NV (ATAI)
2.12
+0.07
(+3.41%)
USD |
NASDAQ |
May 02, 16:00
2.13
+0.01
(+0.47%)
Pre-Market: 08:15
ATAI Life Sciences Revenue (Quarterly): 0.018M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.018M |
| September 30, 2023 | 0.087M |
| June 30, 2023 | 0.172M |
| March 31, 2023 | 0.037M |
| December 31, 2022 | 0.038M |
| September 30, 2022 | 0.024M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.17M |
| March 31, 2022 | |
| December 31, 2021 | 0.23M |
| September 30, 2021 | 0.266M |
| June 30, 2021 | |
| March 31, 2021 | 19.88M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.018M
Minimum
Dec 2023
19.88M
Maximum
Mar 2021
2.092M
Average
0.1285M
Median
Revenue (Quarterly) Benchmarks
| Affimed NV | 0.4448M |
| InflaRx NV | 0.0025M |
| MorphoSys AG | 63.62M |
| BioNTech SE | 1.593B |
| Immatics NV | 17.15M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.29M |
| Total Expenses (Quarterly) | 31.13M |
| EPS Diluted (Quarterly) | -0.11 |
| Enterprise Value | 191.95M |
| Profit Margin (Quarterly) | -101.6K% |
| Earnings Yield | -13.21% |
| Normalized Earnings Yield | -35.26 |